Literature DB >> 1280383

5' end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5' untranslated region.

B J Yoo1, R R Spaete, A P Geballe, M Selby, M Houghton, J H Han.   

Abstract

Hepatitis C virus (HCV) is a distant relative of pestiviruses and flaviviruses, but it has a 5' untranslated region (UTR) with some features structurally similar to that of picornaviruses. In order to test the role of the 5' UTR in controlling the expression of the HCV polyprotein, we fused full-length or deleted versions of the 5' UTR of HCV-1 RNA to chloramphenicol acetyl transferase (CAT) mRNA to monitor CAT activity in vivo. We found: (1) the full-length 5' UTR of HCV-1 RNA is translationally inactive while 5' deletions which mimic a 5' subgenomic RNA detected in vivo are active, (2) an efficient cis-acting element which represses translation is found at the 5' terminus, (3) a putative element which enhances translation is found near the 3' terminus of the 5' UTR, (4) additional cis-acting elements including small open reading frames (ORFs) upstream from the putative enhancer element downregulate translation. We did not find evidence supporting the existence of an internal ribosome entry site in the 5' UTR of HCV-1 RNA. These data suggest that HCV may employ a distinctive translation control strategy such as the generation of subgenomic viral mRNA in infected cells. Translational control of HCV might be responsible for some of the characteristic pathobiology seen in viral infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280383     DOI: 10.1016/0042-6822(92)90264-p

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

Review 1.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

2.  Functional analysis of the interaction between HCV 5'UTR and putative subunits of eukaryotic translation initiation factor eIF3.

Authors:  E Buratti; S Tisminetzky; M Zotti; F E Baralle
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

3.  Coding sequences enhance internal initiation of translation by hepatitis A virus RNA in vitro.

Authors:  J Graff; E Ehrenfeld
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Mutational analysis of the hepatitis C virus RNA helicase.

Authors:  D W Kim; J Kim; Y Gwack; J H Han; J Choe
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism.

Authors:  C Wang; P Sarnow; A Siddiqui
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Specificity of the hepatitis C virus NS3 serine protease: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing.

Authors:  A A Kolykhalov; E V Agapov; C M Rice
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 7.  Recent advances in hepatitis C virus research.

Authors:  M Omata; N Kato
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

8.  In vitro selection of an RNA sequence that interacts with high affinity with thymidylate synthase.

Authors:  X Lin; N Mizunuma; T Chen; S M Copur; G F Maley; J Liu; F Maley; E Chu
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

9.  Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The Netherlands.

Authors:  G E Kleter; L J van Doorn; J T Brouwer; S W Schalm; R A Heijtink; W G Quint
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

10.  A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA.

Authors:  C Wang; P Sarnow; A Siddiqui
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.